Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 270002, China
NCT Number: NCT06720428
To built a dry eye acupoint therapeutic instrument by stimulating acupoints with low impulse current .And the safety of the dry eye acupoint treatment device will be tested and the initial validation will be verified.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 270002, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Those who met the above criteria could be included in the study.
Exclusion criteria
(9)Patients with serious life-threatening primary diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic system diseases, as well as mental illness; (10)Attending other clinical trials.
The dry eye acupuncture point treatment device treat dry eye through stimulating acupuncture points by low pulse current.
0.3% Ali eye drops
Time frame: baseline and 8 weeks post-treatment
The Schirmer test uses filter paper to wick up tears and measure the amount of production.
Time frame: baseline and 8 weeks post-treatment
The time interval between keeping eyes open after blinking until the first dry spot appears on the tear film surface is one of the important criteria to evaluate the stability of tear film.
Time frame: baseline and 8 weeks post-treatment
The most commonly used questionnaire in clinical diagnosis of dry eye. It is mainly used to diagnose dry eye and assess the severity of the condition
Time frame: baseline and 8 weeks post-treatment
Corneal fluorescein staining (CFS) is a valuable clinical tool to assess the viability of the epithelium.
Time frame: baseline and 8 weeks post-treatment
Meibomian Gland (MG) expressibility and secretion quality
Shanghai 10th People's Hospital
Other
Development of a Prototype of Acupoint Therapy Device for Dry Eye and Preliminary Verification of Its Clinical Efficacy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07298811
Dry Eye, Dry Eye Syndromes
Nanchang, Jiangxi, China
View Trial DetailsNCT07175909
Dry Eye, Dry Eye Disease (DED)
Hong Kong
View Trial DetailsNCT07816419
Arthralgia, Asthenopia
Riyadh, Saudi Arabia
View Trial DetailsNCT03937882
Dry Eye, Dry Eye Syndromes
Phoenix, Arizona, United States
View Trial Details